Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Awss Shalhoub"'
Autor:
Francesco Franchi, Luis Ortega-Paz, Fabiana Rollini, Mattia Galli, Latonya Been, Ghussan Ghanem, Awss Shalhoub, Tiffany Ossi, Andrea Rivas, Xuan Zhou, Andres M. Pineda, Siva Suryadevara, Daniel Soffer, Martin M. Zenni, Birgit Reiter, Bernd Jilma, Dominick J. Angiolillo
Publikováno v:
JACC: Cardiovascular Interventions. 16:36-46
Autor:
Luis Ortega-Paz, Francesco Franchi, Fabiana Rollini, Mattia Galli, Latonya Been, Ghussan Ghanem, Awss Shalhoub, Tiffany Ossi, Andrea Rivas, Xuan Zhou, Andres M Pineda Maldonado, Siva Suryadevara, Daniel Soffer, Martin M. Zenni, Lisa K Jennings, Dominick Angiolillo
Publikováno v:
Thrombosis and Haemostasis.
Background:To date, there is no data on switching to dual pathway inhibition (DPI) patients who have completed a guideline-recommended dual antiplatelet therapy (DAPT) regimen. Objectives: To assess the feasibility of switching from DAPT to DPI and t
Autor:
Salvatore Giordano, Francesco Franchi, Luis Ortega-paz, Fabiana Rollini, Mattia Galli, Latonya Been, Ghussan Ghanem, Awss Shalhoub, Tiffany Ossi, Andrea Rivas, Xuan Zhou, Andres M Pineda, Siva Suryadevara, Daniel Soffer, Martin M Zenni, Birgit Reiter, Bernd Jilma, Dominick J Angiolillo
Publikováno v:
European Heart Journal Supplements. 24
Objectives To rule out a drug-drug interaction (DDI) among cangrelor-treated patients who have been pre-treated with ticagrelor. Background There are no studies specifically designed to rule out a DDI when cangrelor is used among patients who have be
Autor:
Salvatore Giordano, Luis Ortega-paz, Francesco Franchi, Fabiana Rollini, Mattia Galli, Latonya Been, Ghussan Ghanem, Awss Shalhoub, Tiffany Ossi, Andrea Rivas, Xuan Zhou, Andres M. Pineda, Siva Suryadevara, Daniel Soffer, Martin M. Zenni, Lisa K Jennings, Dominick J. Angiolillo
Publikováno v:
European Heart Journal Supplements. 24
Aims To assess the feasibility of switching from dual antiplatelet therapy (DAPT) to dual pathway inhibition (DPI) and to compare the pharmacodynamic (PD) profiles of these treatment regimens. Methods and results This was a prospective, randomized, P
Autor:
Francesco, Franchi, Luis, Ortega-Paz, Fabiana, Rollini, Mattia, Galli, Latonya, Been, Ghussan, Ghanem, Awss, Shalhoub, Tiffany, Ossi, Andrea, Rivas, Xuan, Zhou, Andres M, Pineda, Siva, Suryadevara, Daniel, Soffer, Martin M, Zenni, Dominick J, Angiolillo
Publikováno v:
JACC. Cardiovascular interventions.
To rule out a drug-drug interaction (DDI) among cangrelor-treated patients who have been pre-treated with ticagrelor.There are no studies specifically designed to rule out a DDI when cangrelor is used among patients who have been pre-treated with tic
Autor:
Martin M. Zenni, Francesco Franchi, Mattia Galli, Andres M. Pineda, Xuan Zhou, Latonya F. Been, Siva Suryadevara, Ghussan Ghanem, Dominick J. Angiolillo, Theodore A. Bass, Andrea Rivas, Daniel Soffer, Awss Shalhoub, Fabiana Rollini
Publikováno v:
JACC: Cardiovascular Interventions. 14:2410-2412
Autor:
Maelle Saliba, Rana El Hajj, Awss Shalhoub, Suad Taraif, Asif Loya, Mohammad Adib Houreih, Ibrahim Khalifeh
Publikováno v:
International journal of dermatology. 58(7)
Background Cutaneous leishmaniasis (CL) remains a prioritized neglected tropical disease. CL novel presentations call for updating its features. Methods A multiregional cohort of 396 patients with confirmed CL was reviewed. Lesion's clinical stage an